CN Patent

CN101677943B — 使用苯甲醇的多剂量浓缩艾司洛尔

Assigned to Baxter Healthcare SA · Expires 2013-10-23 · 13y expired

What this patent protects

本发明公开了基本上不含其它有关的艾司洛尔酯的浓缩的艾司洛尔注射剂和稀释的艾司洛尔组合物。浓缩艾司洛尔制剂包含约25-1000mg/ml的艾司洛尔和约1-25％w/v的苯甲醇及其组合。组合物还可用作多剂量组合物。本发明还公开了通过稀释本发明的浓缩品而制备的稀释的即用艾司洛尔组合物。本发明还公开了制备和使用本发明即用组合物的方法。

USPTO Abstract

本发明公开了基本上不含其它有关的艾司洛尔酯的浓缩的艾司洛尔注射剂和稀释的艾司洛尔组合物。浓缩艾司洛尔制剂包含约25-1000mg/ml的艾司洛尔和约1-25％w/v的苯甲醇及其组合。组合物还可用作多剂量组合物。本发明还公开了通过稀释本发明的浓缩品而制备的稀释的即用艾司洛尔组合物。本发明还公开了制备和使用本发明即用组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101677943B
Jurisdiction
CN
Classification
—
Expires
2013-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Baxter Healthcare SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.